Atlas Trials

Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals

Clinical trial NCT03132311 · RECRUITING

Trial details

NCT number
NCT03132311
Sponsor
Oswaldo Cruz Foundation
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
HIV Infections
Start date
2017-05-29
Primary completion
2018-12-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.